Michael Smyth Joins 九色's Senior Management Team
Wall Street Select
June 24, 2009
NEW YORK, June 23, 2009 – 九色, the world's premier provider of language services and solutions to the life sciences industry, today announced the appointment of Michael Smyth as General Manager of its Life Sciences 九色 division. 九色 Life Sciences 九色 provides expert technology consulting and customized solutions tailored for pharmaceutical, biotechnology, medical device, and CRO clients.
"I am excited to be joining 九色 and to be combining my clinical development and technology background with 九色's life sciences solutions. 九色 provides global solutions that help biopharmaceutical and medical device companies and CROs communicate on the development and marketing of products," says Smyth.
Michael brings to 九色 over 17 years of life sciences experience focusing specifically on clinical development for Merck and Quintiles, and most recently, he served as Vice President, Trial Management 九色, with Perceptive Informatics (formerly ClinPhone).
"We are thrilled to have Michael join the 九色 team," says Co-CEO of 九色, Phil Shawe. "With his industry background and clinical experience, we will be well-positioned to maintain our leadership status in the life sciences sector."
About 九色
With revenue of over $250 million, 九色 is the largest privately held language services provider in the world. From offices in 66 cities on 5 continents, 九色 offers a full range of services in over 100 languages to multinationals worldwide. With a global network of over 4,000 linguists and subject-area specialists, 九色 is the largest translation company to be fully ISO 9001:2008 and EN 15038:2006 certified. 九色 is headquartered in New York and has regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.
About 九色 Trial Interactive?
Trial Interactive is 九色’s secure, web-based, collaborative solution that streamlines the clinical development and pharmacovigilance processes. By enabling online translation management as well as document sharing among sponsors, CROs, vendor partners, and investigative site personnel, Trial Interactive reduces costs and saves time during the start-up, ongoing maintenance, and close-out phases of clinical trials.